HOSPITAL ACQUIRED INFECTIONS MARKET GLOBAL ESTIMATION CROSSES $36.16 BN TILL 2023 – BY STERIS CORPORATION, GETINGE AB, CANTEL MEDICAL CORP., BELIMED AG, AND OTHERS

The Global Hospital Acquired Infection Market is expected to catapult to USD 36.16 billion by the end of 2022 from USD 23.7 billion in 2016, reveals Market Research Future (MRFR) in a minutely analyzed research report. Despite being equipped with state-of-the-art disinfecting technologies, hospital acquired infections continue to prevail in hospitalized patients and are the primary driver of the market which will help it to capture a CAGR of 7.3% over the forecast period of 2013-2022.

The market’s driving factors are nature and virulence of the microbial agent, patient susceptibility such as immunity, presence of other diseases, environmental factors such as infected materials and bacterial load in hospitals, crowding, temperature and humidity etc., bacterial resistance to drugs, the age of patient., high prevalence of HAI, lack of awareness, poor training and infection control practices, poor hospital infrastructure and regulation, low expenditure on healthcare, rise of chronic diseases with prolonged stay in hospitals etc.

The Global market for hospital acquired infections was $23.7 billion in 2016 and is expected to reach around $36.16 billion by the end of the forecast period growing at a CAGR of 7.3%.

Download PDF Sample Copy of "Hospital Acquired Infections Market" Report @ https://www.marketresearchfuture.com/sample_request/2576

Industry Updates

In June 2018, Zurex Pharma, a developer of antimicrobial products for hospital acquired infections raised USD 9 Million to fight hospital acquired The company plans to invest the sum in the development of ZurexPrep, a pre-surgical skin preparation.
In May 2018, PCT LTD, formerly Bingham Canyon Corporation, launched a novel disinfecting system that is designed to reduce hospital acquired Annihilyzer® Infection Control System is created through electrolytic process and is devoid of any harsh or toxic chemicals.
Key Players for Global Hospital Acquired Infections Market

Some of the key players in this market are:

Advanced Sterilization Products,

3M Company,

Becton Dickinson and company,

STERIS Corporation,

Getinge AB,

Cantel Medical Corp.,

Belimed AG, and others.

Regional Analysis for Global Hospital Acquired Infections Market

The key markets of the global hospital acquired infection market include the Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas are the largest market for hospital acquired infection. The Europe accounts for the second largest share of the market and is followed by Asia Pacific which is slated to emerge as the fastest growing market. The Middle East & Africa market is also expected to exhibit potential growth over the forecast period owing to lack of proper healthcare infrastructure and poor hygienic conditions in the underdeveloped regions which provides room for market expansion.

Segments for Global Hospital Acquired Infections Market

Global Hospital Acquired Infections Market has been segmented on the basis of pathogen types which comprises of viral, bacterial and fungal. On the basis of method of treatment the market is segmented into sterilization, chemical, radiation and on the basis of infection type market is segmented into urinary tract infections, blood stream infections, surgical site infections, gastrointestinal infections, and respiratory infections.

Browse Complete Report @ https://www.marketresearchfuture.com/reports/hospital-acquired-infections-market-2576

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Hadapsar, Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.